Showing results (71-80 of 417) with videos related to
Sort By:
Pageof 42
Current Opinion in Pharmacology|August 8, 2021
Treatment of severe alcoholic hepatitis: A systematic reviewLukas Van Melkebeke, Hannelie Korf, Emmanuel A Tsochatzis, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 5, 2019
Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver diseaseCristina Stasi, Emmanuel A Tsochatzis, Andrew Hall, et al.Digestive Diseases (Basel, Switzerland)|July 11, 2015
Pathophysiology and a Rational Basis of TherapyJordi Gracia-Sancho, Raquel Maeso-Díaz, Jaime BoschExpert Review of Gastroenterology & Hepatology|February 1, 2013
Assessing portal hypertension in liver diseasesAnnalisa Berzigotti, Susana Seijo, Enric Reverter, et al.Expert Opinion on Investigational Drugs|June 27, 2022
Investigational drugs in early clinical development for portal hypertensionSusana G Rodrigues, Yuly P Mendoza, Jaime BoschPlos One|February 19, 2013
A non-invasive stress assay shows that tadpole populations infected with Batrachochytrium dendrobatidis have elevated corticosterone levelsCaitlin R Gabor, Matthew C Fisher, Jaime BoschJHEP Reports : Innovation in Hepatology|February 11, 2020
Beta-blockers in cirrhosis: Evidence-based indications and limitationsSusana G Rodrigues, Yuly P Mendoza, Jaime BoschGut|March 7, 2020
Cirrhosis as new indication for statinsJaime Bosch, Jordi Gracia-Sancho, Juan G AbraldesOecologia|May 5, 2023
Drivers of Batrachochytrium dendrobatidis infection load, with evidence of infection tolerance in adult male toads (Bufo spinosus)Jaime Bosch, Barbora Thumsová, Robert Puschendorf, et al.Plos One|April 21, 2015
Elevated Corticosterone Levels and Changes in Amphibian Behavior Are Associated with Batrachochytrium dendrobatidis (Bd) Infection and Bd LineageCaitlin R Gabor, Matthew C Fisher, Jaime BoschPageof 42